LURATI, ALFREDOMARIA
LURATI, ALFREDOMARIA
Universita' degli Studi di MILANO
Anti-Cyclic Citrullinated Peptide Antibodies in Juvenile Idiopathic Arthritis (jia). A Monocentric Cross-Sectional Study
2005-01-01 V. Gerloni, A. Lurati, B. Teruzzi, C. Crapanzano, M. Gattinara, F. Fantini
Efficacy of a second TNFAlpha blocker when the first one failed in patients with juvenile idiopathic arthritis (JIA) treated with Infliximab, Etanercept and Adalimubab
2008-01-01 A. Salmaso, V. Gerloni, A. Lurati, I. Pontikaki, B. Teruzzi, M. Gattinara, F. Fantini
Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis : results of an open-label prospective study
2005-01-01 V. Gerloni, I. Pontikaki, M. Gattinara, F. Desiati, E. Lupi, A. Lurati, A. Salmaso, F. Fantini
Long-Term Evaluation (Efficacy and Safety) of Infliximab in the Treatment of Persistently Active Juvenile Idiopathic Arthritis (JIA), Refractory to Standard Treatments
2005-01-01 V. Gerloni, I. Pontikaki, G. De Marco, M. Gattinara, E. Valcamonica, A. Lurati, A. Salmaso, B. Teruzzi, F. Fantini
Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy
2007-01-01 G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini
Side Effects of Anti-Tnfα Therapy in Jia, in an Open Monocentric Prospective Study of 151 Patients
2005-01-01 I. Pontikaki, V. Gerloni, A. Lurati, M. Gattinara, A. Salmaso, E. Valcamonica, G. De Marco, B.L. Teruzzi, F. Fantini
Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis
2008-01-01 A. Lurati, R. Cimaz, M. Gattinara, V. Gerloni, B. Teruzzi, A. Salmaso, F. Fantini